NCT05194982View on ClinicalTrials.gov

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

PHASE1RecruitingINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Locally Advanced or Metastatic Solid Tumor
Interventions
DRUG

BL-B01D1

Administration by intravenous infusion.

Trial Locations (8)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

Unknown

RECRUITING

Chongqing University Cancer Hospital, Chongqing

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

RECRUITING

Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Shanghai Oriental Hospital, Shanghai

RECRUITING

Shanxi Cancer Hospital, Taiyuan

All Listed Sponsors
collaborator

SystImmune Inc.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY